Food companies are being warned that choosing to ignore genomic evidence is no longer a viable legal strategy. When genomic data reveals contamination, pretending not to know is viewed as willful blindness.
According to Food Safety News, juries are quick to understand this lack of oversight. For businesses, the ability to track pathogens through their genome means that avoiding these tests is seen as a deliberate choice to ignore risks.
